In the recent march newsletter avx is again reminding us that when the $79.9mil was raised, this was enough to complete phase3. Because of the FDA's requirement of a larger trial it looks like it won't be enough. So I hope we get a takeover or partner, otherwise another capital raising is on the way, which is probably holding down the SP as well as the traders.
Add to My Watchlist
What is My Watchlist?